<DOC>
	<DOC>NCT02458651</DOC>
	<brief_summary>The purpose of this observational study is to describe patient and disease characteristics as well as treatment patterns in Chinese patients with unresectable stage IIIB or IV non-small cell lung cancer (NSCLC). In addition, this study characterizes the clinical outcomes for various populations of patients defined by clinical and tumor characteristics, treatment patterns, and hospital category defined by city tier and geographic region.</brief_summary>
	<brief_title>Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Histologically/cytologically confirmed, unresectable Stage IIIB or IV nonsmall cell lung cancer (NSCLC) Received at least one anticancer treatment targeting unresectable Stage IIIB or IV NSCLC in the study site after study initiation Radiographic evidence of disease Prior systematic treatment for unresectable Stage IIIB or IV nonsmall cell lung cancer (NSCLC) Participation in any anticancer, regimenspecified clinical study of firstline treatment for unresectable Stage IIIB or IV NSCLC.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>